A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01) A61K 31/415 (2006.01) C07H 19/052 (2006.01)
Patent
CA 2042752
ABSTRACT OF THE DISCLOSURE A composition for the treatment or prevention of multiple sclerosis is disclosed. It comprises mizoribine (4-carbamoyl-1-.beta.-D-ribofuranosyl imidazolium-5-olate) as the effective component. It is a safe drug, exhibiting a minimal degree of side-effects, and thus can be administered over a long period of time. Administration of the drug, usually 1-20 mg/kg (body weight) per day for adults, improves the functional disturbances of multiple sclerosis.
Saida Kyoko
Saida Takahiko
Asahi Kasei Kogyo Kabushiki Kaisha
Gowling Lafleur Henderson Llp
LandOfFree
Novel application of 4-carbamoyl-1- b -d-ribofuranosyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel application of 4-carbamoyl-1- b -d-ribofuranosyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel application of 4-carbamoyl-1- b -d-ribofuranosyl... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1597337